A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities.

Saved in:
Bibliographic Details
Title: A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities.
Authors: Namjoo, Mohadeseh1 (AUTHOR), Ghafouri, Hossein2 (AUTHOR) h.ghafoori@guilan.ac.ir, Assareh, Elham2 (AUTHOR) assareh.elham7@gmail.com, Aref, Amir Reza3 (AUTHOR) amir@xspherabio.com, Mostafavi, Ebrahim4 (AUTHOR) ebimsv@stanford.edu, Hamrahi Mohsen, Ali5 (AUTHOR) hamrahi.ali.1992@gmail.com, Balalaie, Saeed6 (AUTHOR) balalaie@kntu.ac.ir, Broussy, Sylvain7 (AUTHOR) sylvain.broussy@parisdescartes.fr, Asghari, S. Mohsen5 (AUTHOR) sm.asghari@ut.ac.ir
Source: Pharmaceuticals (14248247). Jun2023, Vol. 16 Issue 6, p906. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14248247
DOI:10.3390/ph16060906